Patents-Review.com
ClassID:

20537 ⎘

A61K31/713 - page 5 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having three or more nucleosides or nucleotides Double-stranded nucleic acids or oligonucleotides

Recent Application in this class:
#1201
20210186877
2021-06-24

Methods for production of MSC-derived exosomes

 #1202
20210180066
2021-06-17

Compositions and methods for inhibiting gene expression of Hif2alpha

 #1203
20210180064
2021-06-17

Exon skipping compositions for treating muscular dystrophy

 #1204
20210180057
2021-06-17

MODULATORS OF ENaC EXPRESSION

 #1205
20210179720
2021-06-17

Nucleic acid-polypeptide compositions and uses thereof

 #1206
20210179719
2021-06-17

Antibody binding to Tie2 and use thereof

 #1207
20210179660
2021-06-17

GLUCOCORTICOID INHIBITORS FOR TREATMENT OF PROSTATE CANCER

 #1208
20210177885
2021-06-17

REAGENTS FOR TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION AND USE THEREOF

 #1209
20210177884
2021-06-17

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #1210
20210177757
2021-06-17

EXOSOMES FOR DELIVERY OF THERAPEUTIC AGENTS

 #1211
20210171959
2021-06-10

Compositions and methods for use in controlling mosquito-borne viruses

 #1212
20210171956
2021-06-10

Glucokinase (GCK) iRNA compositions and methods of use thereof

 #1213
20210171955
2021-06-10

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

 #1214
20210171954
2021-06-10

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

 #1215
20210171636
2021-06-10

Inhibition of cytokine-induced SH2 protein in NK cells

 #1216
20210169973
2021-06-10

Inhibitor of IGFBP3/TMEM219 Axis and Diabetes

 #1217
20210169921
2021-06-10

Modulation of factor 11 expression

 #1218
20210163955
2021-06-03

Endomucin inhibitor as an anti-angiogenic agent

 #1219
20210163952
2021-06-03

TMPRSS6 iRNA compositions and methods of use thereof

 #1220
20210163951
2021-06-03

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

 #1221
20210163949
2021-06-03

Modulation of alternative MDM2 splicing

 #1222
20210163934
2021-06-03

BBB-crossing lipid ligand of hetero nucleic acid

 #1223
20210162053
2021-06-03

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

 #1224
20210162050
2021-06-03

TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT

 #1225
20210162022
2021-06-03

Sequence specific antimicrobials

 #1226
20210161825
2021-06-03

CHLOROQUINE-BASED MATERIALS FOR THE TREATMENT OF DISEASES

 #1227
20210161818
2021-06-03

Preparation and storage of liposomal RNA formulations suitable for therapy

 #1228
20210156844
2021-05-27

TMEM16A Modulation for Diagnostic or Therapeutic Use in Pulmonary Hypertension (PH)

 #1229
20210155937
2021-05-27

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

 #1230
20210155934
2021-05-27

ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS

 #1231
20210155697
2021-05-27

Antibodies directed to Tie-2 and methods of use

 #1232
20210154222
2021-05-27

Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor

 #1233
20210147853
2021-05-20

Use of trinucleotide repeat RNAs to treat cancer

 #1234
20210147848
2021-05-20

PLANT SRNA EXTRACT FOR USE AS AN IMMUNOSUPPRESSIVE AGENT

 #1235
20210147836
2021-05-20

Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity

 #1236
20210139994
2021-05-13

Methods and compositions related to T-cell activity

 #1237
20210139916
2021-05-13

FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING

 #1238
20210139896
2021-05-13

Peptide oligonucleotide conjugates

 #1239
20210137963
2021-05-13

Treatment of aberrant fibroblast proliferation

 #1240
20210137875
2021-05-13

TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM

 #1241
20210130823
2021-05-06

COMPOSITIONS AND METHODS

 #1242
20210130448
2021-05-06

Brain-specific angiogenesis inhibitor 1 (BAI1) antibodies and uses thereof

 #1243
20210130403
2021-05-06

Inhibitors of metastasis

 #1244
20210123913
2021-04-29

COMPOSITIONS AND METHODS FOR MODULATING HYDROXYLATION OF ACC2 BY PHD3

 #1245
20210121496
2021-04-29

METHODS AND COMPOSITIONS FOR MODULATING CANCER STEM CELLS

 #1246
20210121495
2021-04-29

Methods for treating triple-negative breast cancer

 #1247
20210121438
2021-04-29

METHODS FOR TREATING OR PREVENTING CONFORMATION DISEASES AND METHODS FOR DRUG SCREENING

 #1248
20210115445
2021-04-22

CHANNEL MODULATORS

 #1249
20210115440
2021-04-22

Composition for delivering nucleic acid and nucleic acid-containing composition

 #1250
20210115142
2021-04-22

Recombinant protein targeting PD-1 and TGFß

 #1251
20210113604
2021-04-22

Methods of attenuating an immune response by inhibition of BFL1

 #1252
20210113603
2021-04-22

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

 #1253
20210109112
2021-04-15

Method of treating and prognosing scoliotic patient subgroups

 #1254
20210108228
2021-04-15

Method for treatment of a leukocyte related disease by delivery of nucleic acid molecules to leukocytes using targeted lipid particles

 #1255
20210108210
2021-04-15

MUCOSAL HEALING PROMOTER

 #1256
20210108206
2021-04-15

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

 #1257
20210108201
2021-04-15

FN3 domain-siRNA conjugates and uses thereof

 #1258
20210108200
2021-04-15

BRANCHED LIPID CONJUGATES OF siRNA FOR SPECIFIC TISSUE DELIVERY

 #1259
20210102215
2021-04-08

TREATMENT AND PREVENTION OF VIRAL INFECTION

 #1260
20210102209
2021-04-08

Compositions and Methods for Treating, Ameliorating, and/or Preventing Viral Infections

 #1261
20210102208
2021-04-08

COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER

 #1262
20210101977
2021-04-08

Antibodies that specifically bind human CD96

 #1263
20210095048
2021-04-01

PSMD9 inhibitors for the treatment of hepatic lipid dysregulation

 #1264
20210093655
2021-04-01

Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders

 #1265
20210093654
2021-04-01

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER

 #1266
20210087566
2021-03-25

Compositions and methods for modulating apolipoprotein (a) expression

 #1267
20210087558
2021-03-25

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

 #1268
20210087556
2021-03-25

Therapeutic agent for fibrosis

 #1269
20210087247
2021-03-25

MPS PEPTIDES AND USE THEREOF

 #1270
20210087135
2021-03-25

Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents

 #1271
20210085803
2021-03-25

METHOD FOR OPENING TIGHT JUNCTIONS

 #1272
20210078936
2021-03-18

Lipids and lipid compositions for the delivery of active agents

 #1273
20210077520
2021-03-18

Vesicles comprising a PTEN inhibitor and uses of same

 #1274
20210077399
2021-03-18

MAGNETIC LIPOSOMES AND RELATED TREATMENT AND IMAGING METHODS

 #1275
20210077397
2021-03-18

Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents

 #1276
20210072244
2021-03-11

METHODS AND COMPOSITIONS FOR TREATING MELANOMA RESISTANT

 #1277
20210070820
2021-03-11

NFAT binding polynucleotides

 #1278
20210069343
2021-03-11

Antibody-drug conjugates and uses thereof

 #1279
20210069238
2021-03-11

Methods of making novel pharmaceutical compositions

 #1280
20210068402
2021-03-11

Methods and compositions for control of arthropod pests

 #1281
20210062198
2021-03-04

Interfering RNA molecules

 #1282
20210062195
2021-03-04

RNA interference in ocular indications

 #1283
20210062193
2021-03-04

Plant sRNA extract or plant miRNA for use as an immunosuppressive agent

 #1284
20210062190
2021-03-04

Hippo and dystrophin complex signaling in cardiomyocyte renewal

 #1285
20210062189
2021-03-04

Extended dicer substrate agents and methods for the specific inhibition of gene expression

 #1286
20210061915
2021-03-04

Compositions and methods for treating and preventing inflammation

 #1287
20210060177
2021-03-04

Lipid nanoparticle compositions and methods for mRNA delivery

 #1288
20210060141
2021-03-04

Sequence specific antimicrobials

 #1289
20210060140
2021-03-04

Sequence specific antimicrobials

 #1290
20210060055
2021-03-04

Methods and compositions for treating cancers using antisense

 #1291
20210060054
2021-03-04

Pharmaceutical composition comprising particles and methods of making same

 #1292
20210060053
2021-03-04

Development of polylysine:epigallocatechin-3-o-gallate and dsRNA polyplexes for control of mosquitoes

 #1293
20210060052
2021-03-04

IN SITU METHODS OF INDUCING OF IMMUNE RESPONSE

 #1294
20210059945
2021-03-04

Oral Drug Delivery System and Method for Fabricating Thereof

 #1295
20210054381
2021-02-25

Oligomers and oligomer conjugates

 #1296
20210054380
2021-02-25

Interferon production using short RNA duplexes

 #1297
20210054378
2021-02-25

Nucleic acid simultaneously inhibiting expression of mTOR gene and STAT3 gene

 #1298
20210054344
2021-02-25

CPC EXOSOMES MIRNA373 COMBINATION THERAPIES

 #1299
20210052736
2021-02-25

COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES

 #1300
20210052626
2021-02-25

Compositions and methods for treating malignant, autoimmune and inflammatory diseases

 #1301
20210052625
2021-02-25

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

 #1302
20210052624
2021-02-25

RNAi therapy for hepatitis B virus infection

 #1303
20210052623
2021-02-25

LIQUID COMPOSITION CONTAINING HIGH CONCENTRATION OF DNA FRAGMENT MIXTURE AND HAVING FLUIDITY AND PREPARATION METHOD THEREFOR

 #1304
20210046185
2021-02-18

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

 #1305
20210046074
2021-02-18

INHIBITORS OF IMMUNE CHECKPOINT MODULATORS AND RELATED METHODS

 #1306
20210040478
2021-02-11

Method of fixing and expressing physiologically active substance

 #1307
20210040201
2021-02-11

Anti-TIGIT antibody and use thereof

 #1308
20210038733
2021-02-11

Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof

 #1309
20210038643
2021-02-11

Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells

 #1310
20210038630
2021-02-11

Immune modulation with TLR9 agonists for cancer treatment

 #1311
20210038553
2021-02-11

Use of APE1/Ref-1 inhibitors for treatment of retinal diseases

 #1312
20210032625
2021-02-04

Transgenic microalgae and use thereof as a feed for delivery of interfering RNA molecules

 #1313
20210032310
2021-02-04

APOM-FC FUSION PROTEINS AND USES THEREOF

 #1314
20210032290
2021-02-04

Peptides and nanoparticles for intracellular delivery of molecules

 #1315
20210032282
2021-02-04

Nucleic acid complex, method for forming nucleic acid hybridization, pharmaceutical composition, nucleic acid probe, and complementary-strand nucleic acid complex

 #1316
20210030883
2021-02-04

Compositions and methods for transport across the blood brain barrier

 #1317
20210030781
2021-02-04

AGENTS AND METHODS FOR TREATING PANCREATIC DUCTAL ADENOCARCINOMAS

 #1318
20210024937
2021-01-28

Methods of Modulating Lymphangiogenesis, E.g., to Treat Corneal Transplant Rejection, in a Subject

 #1319
20210024923
2021-01-28

COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION

 #1320
20210024915
2021-01-28

METHOD FOR ACTIVATING P21 GENE EXPRESSION

 #1321
20210024649
2021-01-28

Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy

 #1322
20210024645
2021-01-28

CD38 protein antibody and application thereof

 #1323
20210023118
2021-01-28

MLK-regulated microRNAs in angiogenesis and tumor development

 #1324
20210023117
2021-01-28

In vitro and in vivo intracellular delivery of siRNA via self-assembled nanopieces

 #1325
20210023116
2021-01-28

TREATMENT OF CANCER BY SYSTEMIC ADMINISTRATION OF DBAIT MOLECULES

 #1326
20210018518
2021-01-21

METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES

 #1327
20210017521
2021-01-21

Inhibitors of micro-RNA 22

 #1328
20210017520
2021-01-21

Micro-RNA and obesity

 #1329
20210017497
2021-01-21

Compositions and methods for cellular reprogramming

 #1330
20210017291
2021-01-21

Reelin antibodies for treatment of atherosclerosis

 #1331
20210015945
2021-01-21

Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them

 #1332
20210015931
2021-01-21

Immunoregulatory protein-siRNA complex having anticancer activity

 #1333
20210008226
2021-01-14

Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety

 #1334
20210008213
2021-01-14

Nanostructured gels capable of controlled release of encapsulated agents

 #1335
20210008181
2021-01-14

Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors

 #1336
20210008109
2021-01-14

METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS

 #1337
20210008054
2021-01-14

Use of CDK9 inhibitors to reduce cartilage degradation

 #1338
20210002667
2021-01-07

SYNTHETIC DNA VECTORS AND METHODS OF USE

 #1339
20210002638
2021-01-07

Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof

 #1340
20210002372
2021-01-07

METHODS AND COMPOSITIONS FOR TREATING NATALIZUMAB-ASSOCIATED PROGRESSIVE MULTIFOCAL ENCEPHALOPATHY

 #1341
20210000882
2021-01-07

PRODUCTION AND USE OF EXTRACELLULAR VESICLES

 #1342
20210000856
2021-01-07

Immunomodulatory small hairpin RNA molecules

 #1343
20200407451
2020-12-31

Method of modulating cell proliferation

 #1344
20200405877
2020-12-31

Compositions and methods of treating muscle atrophy and myotonic dystrophy

 #1345
20200405853
2020-12-31

INHIBITOR OF SETDB1 HISTONE METHYLTRANSFERASE FOR USE IN CANCER COMBINATION THERAPY

 #1346
20200405742
2020-12-31

COMPOSITIONS AND METHODS FOR PAIN AMELIORATION IN PATIENT POPULATION THAT SCORES HIGH ON THE PAIN CATASTROPHIZING SCALE

 #1347
20200405735
2020-12-31

Methods and pharmaceutical compositions for treating peripheral demyelinating diseases

 #1348
20200405642
2020-12-31

Tolerogenic liposomes and methods of use thereof

 #1349
20200397906
2020-12-24

Pharmaceutical compositions and related methods of delivery

 #1350
20200397712
2020-12-24

NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES

 #1351
20200397698
2020-12-24

Fusogenic liposome-coated porous silicon nanoparticles

 #1352
20200392508
2020-12-17

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

 #1353
20200392507
2020-12-17

Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis

 #1354
20200392506
2020-12-17

Direct and selective inhibition of MDM4 for treatment of cancer

 #1355
20200392492
2020-12-17

Modulating Immune Responses

 #1356
20200392490
2020-12-17

Compounds and methods for trans-membrane delivery of molecules

 #1357
20200390857
2020-12-17

METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY

 #1358
20200390700
2020-12-17

Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

 #1359
20200385812
2020-12-10

FGFR3 FUSION GENE AND PHARMACEUTICAL DRUG TARGETING SAME

 #1360
20200384266
2020-12-10

Modulation of extracellular vesicles with electrical stimulation

 #1361
20200384062
2020-12-10

USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION

 #1362
20200377893
2020-12-03

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

 #1363
20200377890
2020-12-03

CTLA-4 aptamer conjugates

 #1364
20200376019
2020-12-03

miR29 MIMICS FOR THE TREATMENT OF OCULAR FIBROSIS

 #1365
20200376005
2020-12-03

SHIP INHIBITION TO COMBAT OBESITY

 #1366
20200370051
2020-11-26

MRGPRX2/MRGPRB2 EXPRESSING CELL BASED ASSAY TO DETECT PSEUDO-ALLERGIC DRUG REACTIONS AND TO IDENTIFY BLOCKERS TO PREVENT THE ADVERSE REACTIONS

 #1367
20200369769
2020-11-26

ILDR2 antagonists and combinations thereof

 #1368
20200369703
2020-11-26

Modified oligonucleotides and compound that can be used for synthesizing same

 #1369
20200362351
2020-11-19

Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

 #1370
20200362350
2020-11-19

Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics

 #1371
20200362024
2020-11-19

BIOLOGICAL MATERIALS AND USES THEREOF

 #1372
20200360522
2020-11-19

Nucleic acid, composition and conjugate containing same, preparation method, and use thereof

 #1373
20200360417
2020-11-19

ROR2 inhibitors and use thereof in treating and/or preventing cartilage loss

 #1374
20200360397
2020-11-19

ANTI-VIRAL COMPOSITIONS CONTAINING PIKFYVE INHIBITORS AND USE THEREOF

 #1375
20200353100
2020-11-12

Motor neuron-specific expression vectors

 #1376
20200352979
2020-11-12

COMPOSITIONS AND METHODS FOR TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS

 #1377
20200352978
2020-11-12

MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation

 #1378
20200345866
2020-11-05

Method for treating or preventing heart failure

 #1379
20200345758
2020-11-05

Serum amyloid P component (APCS) iRNA compositions and methods of use thereof

 #1380
20200345757
2020-11-05

Use of specific siRNA against protein S for the treatment of hemophilia

 #1381
20200345756
2020-11-05

COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY

 #1382
20200345741
2020-11-05

TRPC ION CHANNEL INHIBITORS FOR USE IN THERAPY

 #1383
20200339998
2020-10-29

COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #1384
20200339995
2020-10-29

Medicine for treating cancer and method for treating cancer

 #1385
20200339994
2020-10-29

Treatment of HIV

 #1386
20200339992
2020-10-29

RNAi induced huntingtin gene suppression

 #1387
20200339988
2020-10-29

RAAV-based compositions and methods

 #1388
20200338214
2020-10-29

Lipid nanoparticle compositions and methods for mRNA delivery

 #1389
20200338193
2020-10-29

Method of treating a localized fibrotic disorder using an IL-33 antagonist

 #1390
20200338110
2020-10-29

Reducing beta-catenin and IDO expression to potentiate immunotherapy

 #1391
20200338109
2020-10-29

Methods for treating hepatitis B infection

 #1392
20200338108
2020-10-29

Methods for treating hepatitis B infection

 #1393
20200332300
2020-10-22

MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS

 #1394
20200332299
2020-10-22

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (SINA)

 #1395
20200332292
2020-10-22

Dual Targeting siRNA Agents

 #1396
20200331992
2020-10-22

Anti-transthyretin antibodies

 #1397
20200331990
2020-10-22

MOBILIZING HIV-INFECTED CELLS FROM LYMPHATIC RESERVOIRS

 #1398
20200330499
2020-10-22

COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION

 #1399
20200330395
2020-10-22

Modified-RNA nanoparticles for induction of RNA interference

 #1400
20200325481
2020-10-15

ANTISENSE-BASED THERAPEUTICS FOR TARGETING HTRA1 AND METHODS OF USE

 #1401
20200325478
2020-10-15

Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro

 #1402
20200318165
2020-10-08

Rapid Identification of Microorganisms

 #1403
20200318119
2020-10-08

Compositions and Methods for Inhibiting Expression of the PCSK9 Gene

 #1404
20200318111
2020-10-08

RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES

 #1405
20200317769
2020-10-08

POLYPEPTIDES

 #1406
20200317746
2020-10-08

TARGETED AND MODULAR EXOSOME LOADING SYSTEM

 #1407
20200316210
2020-10-08

Cell-penetrating peptides for antisense delivery

 #1408
20200316201
2020-10-08

Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression

 #1409
20200316102
2020-10-08

Methods and pharmaceutical composition for the treatment of neurodegenerative disease

 #1410
20200316084
2020-10-08

METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS

 #1411
20200316054
2020-10-08

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

 #1412
20200308584
2020-10-01

Oligonucleotide compounds for targeting huntingtin mRNA

 #1413
20200308579
2020-10-01

Liposomal spherical nucleic acid (SNA) constructs presenting antisense oligonucleotides (ASO) for specific knockdown of interleukin 17 receptor mRNA

 #1414
20200306378
2020-10-01

Trialkyl cationic lipids and methods of use thereof

 #1415
20200306369
2020-10-01

METHODS AND REAGENTS TO TREAT ALLERGY

 #1416
20200306255
2020-10-01

COMPOSITIONS AND METHODS FOR TREATING NIEMANN PICK C DISEASE

 #1417
20200299698
2020-09-24

Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof

 #1418
20200299415
2020-09-24

Method and carrier complexes for delivering molecules to cells

 #1419
20200297853
2020-09-24

Carbohydrate conjugates as delivery agents for oligonucleotides

 #1420
20200297851
2020-09-24

MULTICOMPONENT DEGRADABLE CATIONIC POLYMERS

 #1421
20200291463
2020-09-17

Nano-plasmonic molecular probes and methods of use

 #1422
20200291406
2020-09-17

PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS

 #1423
20200291405
2020-09-17

HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #1424
20200291131
2020-09-17

Bispecific HER2 antibodies and methods of use

 #1425
20200291109
2020-09-17

Composition to induce bone marrow stem cell mobilization

 #1426
20200289615
2020-09-17

Compositions for treating heart disease by inhibiting the action of mAKAPβ

 #1427
20200289541
2020-09-17

Composition for ameliorating loss of hair and graying of hair, and use thereof

 #1428
20200289540
2020-09-17

Preeclampsia

 #1429
20200289437
2020-09-17

Compositions for Modulating Cancer Stem Cells and Uses Therefor

 #1430
20200283771
2020-09-10

ALBUMIN PRODUCTION AND CELL PROLIFERATION

 #1431
20200283766
2020-09-10

Compositions and Methods for Inhibiting Expression of Transthyretin

 #1432
20200283762
2020-09-10

Reducing nonsense-mediated MRNA decay

 #1433
20200282069
2020-09-10

BIOTIN COMPLEXES FOR TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE

 #1434
20200282060
2020-09-10

NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF

 #1435
20200282027
2020-09-10

SEQUENCE SPECIFIC ANTIMICROBIALS

 #1436
20200282026
2020-09-10

Sequence specific antimicrobials

 #1437
20200282012
2020-09-10

Combination therapy for C3 inhibition

 #1438
20200281953
2020-09-10

COMBINATION TUMOR IMMUNOTHERAPY

 #1439
20200277611
2020-09-03

PRESERVATION OF THE NEUROMUSCULAR JUNCTION AFTER TRAUMATIC NERVE INJURY

 #1440
20200277608
2020-09-03

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

 #1441
20200277598
2020-09-03

Peptide oligonucleotide conjugates

 #1442
20200276263
2020-09-03

Treatments of oxidative stress conditions

 #1443
20200276235
2020-09-03

Combination immunotherapies for treatment of cancer

 #1444
20200276223
2020-09-03

Compositions and methods for treatment of sepsis-related disorders

 #1445
20200276222
2020-09-03

2'-METHOXY SUBSTITUTED OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATIONS

 #1446
20200270615
2020-08-27

siRNA compositions that specifically down regulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease

 #1447
20200270607
2020-08-27

Methods and compositions for selecting siRNA of improved functionality

 #1448
20200269061
2020-08-27

Non-thermal atmospheric-pressure plasma keloid treatment device, and use thereof

 #1449
20200268678
2020-08-27

Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents

 #1450
20200268647
2020-08-27

METHOD OF ENHANCING DELIVERY OF THERAPEUTIC COMPOUNDS TO THE EYE

 #1451
20200263183
2020-08-20

Complement component iRNA compositions and methods of use thereof

 #1452
20200263175
2020-08-20

CHANNEL MODULATORS

 #1453
20200261601
2020-08-20

METHODS FOR INCREASING PLATELET COUNT BY INHIBITING BILIVERDIN IXBETA REDUCTASE

 #1454
20200261491
2020-08-20

Regulation of nucleic acid molecule expression

 #1455
20200261490
2020-08-20

Pappalysin regulator

 #1456
20200255839
2020-08-13

Method for treating a neurological disorder comprising administering ASM inhibitors

 #1457
20200255833
2020-08-13

Therapeutic compositions

 #1458
20200254001
2020-08-13

Therapeutic pharmaceutical composition for cancer including miRNA

 #1459
20200253872
2020-08-13

Liposome compositions and methods of use thereof

 #1460
20200246481
2020-08-06

Antibody-drug conjugates and uses thereof

 #1461
20200246438
2020-08-06

TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY

 #1462
20200246370
2020-08-06

Methods and Compositions for RNAi Mediated Inhibition of Gene Expression in Mammals

 #1463
20200246313
2020-08-06

METHODS FOR DIAGNOSING AND TREATING PROSTATE CANCER

 #1464
20200246267
2020-08-06

Preparation and storage of liposomal RNA formulations suitable for therapy

 #1465
20200246265
2020-08-06

LIPOSOMES COMPRISING POLYMER-CONJUGATED LIPIDS AND RELATED USES

 #1466
20200239912
2020-07-30

Treatment of amyotrophic lateral sclerosis (ALS)

 #1467
20200239889
2020-07-30

Channel modulators

 #1468
20200239887
2020-07-30

Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene

 #1469
20200237971
2020-07-30

Delivery of hydrophobic active agent particles

 #1470
20200237800
2020-07-30

METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISEASE

 #1471
20200237799
2020-07-30

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

 #1472
20200237678
2020-07-30

LIPID NANOPARTICLE MEMBRANE COMPOSITION

 #1473
20200237663
2020-07-30

Method and composition for targeted delivery of therapeutic agents

 #1474
20200237635
2020-07-30

Methods for treating hair loss disorders

 #1475
20200231971
2020-07-23

Methods for treatment of polycystic kidney disease

 #1476
20200231965
2020-07-23

Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors

 #1477
20200230056
2020-07-23

Nanostructured lipid carriers and stable emulsions and uses thereof

 #1478
20200224272
2020-07-16

HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS

 #1479
20200224201
2020-07-16

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

 #1480
20200224200
2020-07-16

MODULATION OF IMMUNE RESPONSE THROUGH STIMULATOR OF INTERFERON GENES

 #1481
20200224198
2020-07-16

COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION

 #1482
20200222467
2020-07-16

Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia

 #1483
20200216847
2020-07-09

Inhibition of LET7I as a means to enhance the protective effect of progesterone against stroke

 #1484
20200216844
2020-07-09

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

 #1485
20200216549
2020-07-09

Compositions and methods to improve anti-angiogenic therapy and immunotherapy

 #1486
20200215113
2020-07-09

CHEMICALLY MODIFIED OLIGONUCLEOTIDES

 #1487
20200209237
2020-07-02

Detection and treatment of autoimmune disorders

 #1488
20200208159
2020-07-02

Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability

 #1489
20200208154
2020-07-02

ALLELE SELECTIVE INHIBITION OF MUTANT C9ORF72 FOCI EXPRESSION BY DUPLEX RNAS TARGETING THE EXPANDED HEXANUCLEOTIDE REPEAT

 #1490
20200208149
2020-07-02

Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

 #1491
20200206362
2020-07-02

Compositions and methods for delivery of agents

 #1492
20200206344
2020-07-02

METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES

 #1493
20200206254
2020-07-02

Methods for reducing or shutting down lactation in non-human mammals and reagents therefor

 #1494
20200206236
2020-07-02

Protection of cells from degeneration and treatment of geographic atrophy

 #1495
20200206145
2020-07-02

Amphiphile-Polymer Particles

 #1496
20200199596
2020-06-25

RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (SINA)

 #1497
20200199592
2020-06-25

siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis

 #1498
20200199591
2020-06-25

Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

 #1499
20200199587
2020-06-25

Functionally-interdependent shape switching nucleic acid nanoparticles

 #1500
20200199064
2020-06-25

Cationic lipids for therapeutic agent delivery formulations